DJ IVD Medical May Continue Gaining Market Share in Hospitals -- Market Talk
0748 GMT - IVD Medical, which is the sole distributor for Sysmex hemostasis IVD products in China, may continue gaining market share in hospitals, Jefferies says. Jefferies initiates coverage on the stock with a buy rating and a target price of HK$5.00. IVD Medical already covers six out of eight IVD segments in China, the U.S. investment bank adds. The medical supplier may also start to expand its profit margins as it starts to increase the breadth of its product offerings, including its self-branded products, the bank says. Shares gain 3.2% to HK$2.92. (yiwei.wong@wsj.com)
(END) Dow Jones Newswires
July 23, 2020 03:48 ET (07:48 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.